- Home
- ANVS vs WIMI Comparison
ANVS vs WIMI Comparison
Compare ANVS & WIMI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ANVS
- WIMI
- Stock Information
- Founded
- ANVS 2008
- WIMI 2015
- Country
- ANVS United States
- WIMI China
- Employees
- ANVS N/A
- WIMI N/A
- Industry
- ANVS Biotechnology: Pharmaceutical Preparations
- WIMI Computer Software: Prepackaged Software
- Sector
- ANVS Health Care
- WIMI Technology
- Exchange
- ANVS Nasdaq
- WIMI Nasdaq
- Market Cap
- ANVS 110.4M
- WIMI 97.0M
- IPO Year
- ANVS 2020
- WIMI 2020
- Fundamental
- Price
- ANVS $9.57
- WIMI $0.88
- Analyst Decision
- ANVS Strong Buy
- WIMI
- Analyst Count
- ANVS 6
- WIMI 0
- Target Price
- ANVS $29.67
- WIMI N/A
- AVG Volume (30 Days)
- ANVS 341.4K
- WIMI 408.8K
- Earning Date
- ANVS 11-06-2024
- WIMI 01-01-0001
- Dividend Yield
- ANVS N/A
- WIMI N/A
- EPS Growth
- ANVS N/A
- WIMI N/A
- EPS
- ANVS N/A
- WIMI N/A
- Revenue
- ANVS N/A
- WIMI $84,137,968.00
- Revenue This Year
- ANVS N/A
- WIMI N/A
- Revenue Next Year
- ANVS N/A
- WIMI N/A
- P/E Ratio
- ANVS N/A
- WIMI N/A
- Revenue Growth
- ANVS N/A
- WIMI 19.25
- 52 Week Low
- ANVS $4.53
- WIMI $0.56
- 52 Week High
- ANVS $22.49
- WIMI $1.87
- Technical
- Relative Strength Index (RSI)
- ANVS 58.70
- WIMI 47.40
- Support Level
- ANVS $9.00
- WIMI $0.88
- Resistance Level
- ANVS $10.54
- WIMI $0.90
- Average True Range (ATR)
- ANVS 0.81
- WIMI 0.04
- MACD
- ANVS 0.12
- WIMI -0.01
- Stochastic Oscillator
- ANVS 74.57
- WIMI 26.76
About ANVS Annovis Bio Inc.
Annovis Bio Inc is a clinical-stage pharmaceutical company focused on developing and commercializing drugs for the treatment of Parkinson's and Alzheimer's diseases and other neurodegenerative diseases. The pipeline products of the company consists of: Buntanetap for chronic neurodegeneration - including AD and PD; ANVS405 for acute neurodegeneration; and ANVS301 for advanced AD.
About WIMI WiMi Hologram Cloud Inc.
WiMi Hologram Cloud Inc and its subsidiaries offer augmented reality (AR) based holographic services and products to cater to its customers. Its AR service and product offerings primarily consist of holographic AR advertising services and holographic AR entertainment products. It is also into the semiconductor business, in which the company provides central processing algorithm services and computer chip products to enterprise customers and the sales of comprehensive solutions for central processing algorithms and related services with software and hardware integration. The company reports in three segments: AR advertising, AR entertainment, and Semiconductor. Its geographical segments are Mainland China, Hong Kong, and International.